Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Stankiewicz

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Neurology|July 17, 2024
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup AnalysesMitzi J Williams, Lilyana Amezcua, Stanley L Cohan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2018
Investigation of probiotics in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Annals of Neurology|April 22, 2018
A probiotic modulates the microbiome and immunity in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2020
Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosisTatenda Dawn Mahlanza, Maria Claudia Manieri, Eric C Klawiter, et al.
Journal of the Neurological Sciences|May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort studyS A Gauthier, B I Glanz, M Mandel, et al.
Archives of Neurology|November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scaleRohit Bakshi, Mohit Neema, Brian C Healy, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Neurology|July 17, 2024
Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup AnalysesMitzi J Williams, Lilyana Amezcua, Stanley L Cohan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 9, 2018
Investigation of probiotics in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Annals of Neurology|April 22, 2018
A probiotic modulates the microbiome and immunity in multiple sclerosisStephanie K Tankou, Keren Regev, Brian C Healy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2020
Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosisTatenda Dawn Mahlanza, Maria Claudia Manieri, Eric C Klawiter, et al.
Journal of the Neurological Sciences|May 12, 2009
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort studyS A Gauthier, B I Glanz, M Mandel, et al.
Archives of Neurology|November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scaleRohit Bakshi, Mohit Neema, Brian C Healy, et al.
Pageof 3